Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
348
-
Total 13F shares, excl. options
-
73.8M
-
Shares change
-
+1.49M
-
Total reported value, excl. options
-
$4.4B
-
Value change
-
+$93.6M
-
Put/Call ratio
-
0.11
-
Number of buys
-
138
-
Number of sells
-
-170
-
Price
-
$59.57
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2022
391 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2022.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 348 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.8M shares
of 115M outstanding shares and own 64.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.26M shares), VANGUARD GROUP INC (7.19M shares), JANUS HENDERSON GROUP PLC (7.04M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (4.56M shares), WELLINGTON MANAGEMENT GROUP LLP (3.65M shares), STATE STREET CORP (2.19M shares), Champlain Investment Partners, LLC (2.04M shares), Capital Research Global Investors (2M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.77M shares), and Invesco Ltd. (1.76M shares).
This table shows the top 348 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.